Lifecore Biomedical, Inc.
LFCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001005286
No open-market purchases or sales by Lifecore Biomedical, Inc. insiders were filed in the last 90 days; 98 institutions reported holding it in 13F filings for Q2 2026, worth $133.3M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Lifecore Biomedical, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 93 | 82 | −11 |
| Shares | 24.7M | 22.7M | −2.03M (−8.2%) |
| Value | $160.0M | $81.7M | −$78.3M (−48.9%) |
New holders (17)
Institutions that held Lifecore Biomedical, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Anson Funds Management LP | 475,062 | $1.79M | 0.56% |
| Nantahala Capital Management, LLC | 194,700 | $735.0K | 0.07% |
| Irenic Capital Management LP | 155,465 | $586.9K | 0.24% |
| Corsair Capital Management, L.P. | 124,928 | $471.6K | 0.18% |
| Diametric Capital, LP | 64,920 | $245.1K | 0.12% |
| Belvedere Trading LLC | 41,176 | $155.4K | 0.07% |
| Prelude Capital Management, LLC | 21,295 | $80.4K | 0.01% |
| Pinnacle Wealth Planning Services, Inc. | 19,025 | $71.8K | 0.01% |
| State of Wisconsin Investment Board | 17,700 | $66.8K | 0.00% |
| Balyasny Asset Management LLC | 17,370 | $65.6K | 0.00% |
| Smith, Moore & Co. | 12,000 | $45.3K | 0.01% |
| Greenhaven Road Investment Management, L.P. | 1,034,449 | $39.0K | 2.24% |
| Covestor Ltd | 2,839 | $11.0K | 0.01% |
| Quadrant Capital Group LLC | 2,416 | $9.12K | 0.00% |
| Global Retirement Partners, LLC | 499 | $2.20K | 0.00% |
| Advisor Group Holdings, Inc. | 409 | $1.54K | 0.00% |
| Massmutual Trust Co FSB | 51 | $193 | 0.00% |
Sold out (28)
Institutions that held Lifecore Biomedical, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.